Mitchell Hoffman

1.3k total citations · 1 hit paper
19 papers, 1.0k citations indexed

About

Mitchell Hoffman is a scholar working on Surgery, Urology and Reproductive Medicine. According to data from OpenAlex, Mitchell Hoffman has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 5 papers in Urology and 4 papers in Reproductive Medicine. Recurrent topics in Mitchell Hoffman's work include Urological Disorders and Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Mitchell Hoffman is often cited by papers focused on Urological Disorders and Treatments (5 papers), Urinary and Genital Oncology Studies (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Mitchell Hoffman collaborates with scholars based in United States and China. Mitchell Hoffman's co-authors include Hector Arango, Rebecca Sutphen, James P. LaPolla, James V. Fiorica, Martin A Martino, Katie Wakeley, George D. Wilbanks, Alan Cantor, Jeffrey P. Krischer and Santo V. Nicosia and has published in prestigious journals such as PLoS ONE, Cancer and The Journal of Urology.

In The Last Decade

Mitchell Hoffman

16 papers receiving 993 citations

Hit Papers

BRCA1 and BRCA2 mutations account for a large proportion ... 2005 2026 2012 2019 2005 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell Hoffman United States 9 441 361 355 239 165 19 1.0k
Hector Arango United States 10 455 1.0× 432 1.2× 373 1.1× 329 1.4× 221 1.3× 15 1.2k
Andreas Doll Spain 20 714 1.6× 93 0.3× 130 0.4× 296 1.2× 344 2.1× 37 1.3k
J A Ruizeveld de Winter Netherlands 9 519 1.2× 71 0.2× 388 1.1× 154 0.6× 180 1.1× 10 1.2k
Aytekin Akyol Türkiye 14 464 1.1× 188 0.5× 154 0.4× 313 1.3× 151 0.9× 40 964
Eva Colás Spain 21 624 1.4× 223 0.6× 103 0.3× 231 1.0× 408 2.5× 42 1.2k
Marina Rigau Spain 16 512 1.2× 106 0.3× 69 0.2× 168 0.7× 336 2.0× 23 925
Ploutarchos Anezinis Greece 15 542 1.2× 19 0.1× 198 0.6× 272 1.1× 162 1.0× 21 1.2k
Wei‐Yu Lin United Kingdom 16 350 0.8× 23 0.1× 111 0.3× 123 0.5× 116 0.7× 44 667
Yuanbin Ru United States 15 846 1.9× 32 0.1× 110 0.3× 357 1.5× 524 3.2× 17 1.3k
Lídia Feliubadaló Spain 15 463 1.0× 25 0.1× 375 1.1× 138 0.6× 172 1.0× 42 1.0k

Countries citing papers authored by Mitchell Hoffman

Since Specialization
Citations

This map shows the geographic impact of Mitchell Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Hoffman more than expected).

Fields of papers citing papers by Mitchell Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Hoffman. The network helps show where Mitchell Hoffman may publish in the future.

Co-authorship network of co-authors of Mitchell Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Hoffman. A scholar is included among the top collaborators of Mitchell Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Hoffman. Mitchell Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Extermann, Martine, Ashwani Kumar Mishra, KaMala S. Thomas, et al.. (2021). Worsening of ovarian cancer prognosis with age: an exploration of pharmacokinetics, body composition, and biology. Journal of Geriatric Oncology. 12(8). S6–S6.
2.
Dobrinski, Kimberly P., Nicole N. Esposito, Patricia A. Kruk, et al.. (2014). Procurement and cytological features of human fallopian tube fimbrial cells by ex vivo imprinting and washing. Journal of the American Society of Cytopathology. 3(6). 309–318.
3.
Shan, Lian, Y. Ann Chen, Gang Han, et al.. (2012). Measurement of Phospholipids May Improve Diagnostic Accuracy in Ovarian Cancer. PLoS ONE. 7(10). e46846–e46846. 23 indexed citations
4.
Bansal, Nisha & Mitchell Hoffman. (2010). Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab. Gynecologic Oncology. 120(2). 313–314. 3 indexed citations
5.
Rodríguez, Alejandro, Tariq S. Hakky, Mitchell Hoffman, Raul Ordorica, & Jorge L. Lockhart. (2010). Salvage Spiral Sling Techniques: Alternatives to Manage Disabling Recurrent Urinary Incontinence in Females. The Journal of Urology. 184(6). 2429–2433. 8 indexed citations
6.
Ordorica, Raul, et al.. (2008). Disabling complications with slings for managing female stress urinary incontinence. British Journal of Urology. 102(3). 333–336. 17 indexed citations
7.
Williams, Vonetta L., Heather Stockwell, K OʼRourke, Mitchell Hoffman, & Jill S. Barnholtz‐Sloan. (2007). Racial Differences in Treatment Modalities for Ovarian Cancer in Florida, 1981–2000. Annals of Epidemiology. 17(9). 727–727. 1 indexed citations
8.
Pal, Tuya, Jenny Permuth‐Wey, Jeffrey P. Krischer, et al.. (2005). BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 104(12). 2807–2816. 524 indexed citations breakdown →
9.
Martino, Martin A, et al.. (2005). Sepsis Leading to Emergent Hysterectomy After Uterine Artery Embolization. Journal of Gynecologic Surgery. 21(4). 173–175.
10.
Griffin, David, Martin A Martino, & Mitchell Hoffman. (2004). Superior vena cava syndrome during chemotherapy for stage 3c fallopian tube adenocarcinoma. Gynecologic Oncology. 93(1). 257–259. 2 indexed citations
11.
Sutphen, Rebecca, Yan Xu, George D. Wilbanks, et al.. (2004). Lysophospholipids Are Potential Biomarkers of Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 13(7). 1185–1191. 294 indexed citations
12.
Bukkapatnam, Satish, John D. Seigne, Julio M. Pow‐Sang, et al.. (2003). Continent Colonic Urinary Reservoir (Florida Pouch): Long-Term Surgical Complications (Greater Than 11 Years). The Journal of Urology. 174–176. 1 indexed citations
13.
Bukkapatnam, Satish, John D. Seigne, Julio M. Pow‐Sang, et al.. (2003). Continent colonic urinary reservoir (Florida pouch): long-term surgical complications (greater than 11 years).. PubMed. 169(1). 174–6. 42 indexed citations
14.
Bukkapatnam, Satish, John D. Seigne, Julio M. Pow‐Sang, et al.. (2003). Continent Colonic Urinary Reservoir (Florida Pouch): Long-Term Surgical Complications (Greater Than 11 Years). The Journal of Urology. 169(1). 174–176. 36 indexed citations
15.
Soto, Roy G., et al.. (2002). Anesthetic Management of Uterine Inversion. Journal of Gynecologic Surgery. 18(4). 165–166. 1 indexed citations
16.
Carrión, Rafael, et al.. (1998). ANTERIOR ENTEROCELE FOLLOWING CYSTECTOMY FOR INTRACTABLE INTERSTITIAL CYSTITIS. The Journal of Urology. 159(6). 1868–1870. 18 indexed citations
17.
Carrión, Rafael, et al.. (1998). ANTERIOR ENTEROCELE FOLLOWING CYSTECTOMY FOR INTRACTABLE INTERSTITIAL CYSTITIS. The Journal of Urology. 1868–1870. 1 indexed citations
18.
Austin, Paul F., et al.. (1996). Urethral obstruction after anti-incontinence surgery in women: Evaluation, methodology, and surgical results. Urology. 47(6). 890–894. 28 indexed citations
19.
DeCesare, Steven, et al.. (1995). Interleukin-12-Mediated Tumoricidal Activity of Patient Lymphocytes in an Autologous in Vitro Ovarian Cancer Assay System. Gynecologic Oncology. 57(1). 86–95. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026